Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Vaccinex's gross profit for the twelve months ending Dec 31, 2020 was $623.00K, up 92.3% year over year. For fiscal 2020 it was $623.00K, up 92.3% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $623.00K | +92.3% |
| FY2019 | Dec 31, 2019 | $324.00K | – |
| FY2018 | Dec 31, 2018 | -$309.00K | – |
| FY2017 | Dec 31, 2017 | -$70.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $623.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $396.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $9.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$81.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$107.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$48.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$120.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$34.00K | – |
See a number that looks wrong?